As of 1:06pm ET
| +0.17 / +4.45%|
The 1 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +275.94% increase from the last price of 3.99.
The current consensus among 3 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.